Sunday, May 13, 2018

HCV in 2018: Success stories and remaining challenges? EASL 2018 Summary from NATAP

Just In Case You Missed It
Coverage highlights of EASL's 2018 International Liver Congress

The National AIDS Treatment Advocacy Project (NATAP)
Available online @ NATAP
May 4, 2018
Summary from EASL 2018 for Hepatitis C (HCV)
HCV in 2018: Success stories and remaining challenges?
With the more recent introduction of the pangenotypic regimens sofosbuvir/velpatasvir and glecaprevir/pibrentasvir, two new fix dose combinations have become available which may even overcome the need for baseline HCV genotype assessment. Larger data sets however, from real-life cohorts still are missing but this gap has been filled at this year EASL.

Healio - HCV Next May/June Issue
May 17, 2018
HCV Next, May/June 2018 Nancy S. Reau, MD 
As we in the United States look ahead to Digestive Disease Week coming up and further to our fall meetings, the International Liver Congress gives us an opportunity to…

HCV Advocate
May 1, 2018
May Newsletter
In this edition of the HCV Advocate we have devoted nearly the entire issue to the 2018 International Liver Congress. Lucinda Porter, RN and I cover some of our favorite posters and presentations in the current issue and in the upcoming June 2018 issue...

infohep bulletin
April 28, 2018
April "infohep bulletin" - Overview of EASL's 2018 International Liver Congress
Patients looking for an overview of EASL's 2018 International Liver Congress can find it in this month's "infohep bulletin"

Clinical Care Options CCO
Expert faculty members summarize key viral hepatitis studies from this important annual conference.
Review Capsules Summaries, download slides, and listen to audio commentary from expert-led Webinars covering critical studies on viral hepatitis.
*Free registration required

Practice Guidelines - EASL Recommendations on Treatment of Hepatitis C 2018
During the meeting The European Association for the Study of the Liver (EASL) released the following four major clinical practice guidelines; hepatocellular carcinoma, decompensated cirrhosis, alcoholic liver diseases and updated recommendations on hepatitis C.

EASL LiverTree - Open To All
This year webcasts and congress materials are open access! Watch freely the conferences and ePosters
*Free registration required

On This Blog
Link to websites offering coverage, meeting highlights, learning activities, and a summary of the meeting, here....

No comments:

Post a Comment